O	0	8	Cosmetic
O	9	16	outcome
O	17	20	and
O	21	29	surgical
O	30	34	site
O	35	44	infection
O	45	50	rates
O	51	53	of
B-intervention	54	67	antibacterial
I-intervention	68	78	absorbable
I-intervention	79	80	(
I-intervention	80	91	Polyglactin
I-intervention	92	95	910
I-intervention	95	96	)
I-intervention	97	103	suture
O	104	112	compared
O	113	115	to
B-control	116	123	Chinese
I-control	124	128	silk
I-control	129	135	suture
O	136	138	in
O	139	145	breast
O	146	152	cancer
O	153	160	surgery
O	160	161	:
O	162	163	a
O	164	174	randomized
O	175	180	pilot
O	181	189	research
O	189	190	.

O	191	194	The
O	195	202	primary
O	203	212	objective
O	213	215	of
O	216	220	this
O	221	232	multicenter
O	233	237	post
O	237	238	-
O	238	244	market
O	245	250	study
O	251	254	was
O	255	257	to
O	258	265	compare
O	266	269	the
O	270	278	cosmetic
O	279	286	outcome
O	287	289	of
O	290	299	triclosan
O	299	300	-
O	300	306	coated
O	307	313	VICRYL
O	314	318	Plus
O	319	326	sutures
O	327	331	with
O	332	339	Chinese
O	340	344	silk
O	345	352	sutures
O	353	356	for
O	357	361	skin
O	362	369	closure
O	370	372	of
O	373	381	modified
O	382	389	radical
O	390	400	mastectomy
O	400	401	.

O	402	403	A
O	404	413	secondary
O	414	423	objective
O	424	427	was
O	428	430	to
O	431	437	assess
O	438	441	the
O	442	451	incidence
O	452	454	of
O	455	463	surgical
O	464	468	site
O	469	478	infection
O	479	480	(
O	480	483	SSI
O	483	484	)
O	484	485	.

B-eligibility	486	494	Patients
I-eligibility	495	505	undergoing
I-eligibility	506	514	modified
I-eligibility	515	522	radical
I-eligibility	523	533	mastectomy
O	534	538	were
O	539	547	randomly
O	548	556	assigned
O	557	559	to
O	560	566	coated
O	567	573	VICRYL
O	574	578	Plus
O	579	592	antibacterial
O	593	594	(
O	594	605	Polyglactin
O	606	609	910
O	609	610	)
O	611	617	suture
O	618	620	or
O	621	628	Chinese
O	629	633	silk
O	634	640	suture
O	640	641	.

O	642	650	Cosmetic
O	651	659	outcomes
O	660	664	were
O	665	674	evaluated
O	675	690	postoperatively
O	691	693	at
O	694	698	days
O	699	701	12
O	702	703	(
O	703	704	±
O	705	706	2
O	706	707	)
O	708	711	and
O	712	714	30
O	715	716	(
O	716	717	±
O	718	719	5
O	719	720	)
O	720	721	,
O	722	725	and
O	726	729	the
O	730	738	evidence
O	739	741	of
O	742	745	SSI
O	746	749	was
O	750	758	assessed
O	759	761	at
O	762	766	days
O	767	768	3
O	768	769	,
O	770	771	5
O	771	772	,
O	773	774	7
O	774	775	,
O	776	778	12
O	779	780	(
O	780	781	±
O	782	783	2
O	783	784	)
O	784	785	,
O	786	788	30
O	789	790	(
O	790	791	±
O	792	793	5
O	793	794	)
O	794	795	,
O	796	799	and
O	800	802	90
O	803	804	(
O	804	805	±
O	806	807	7
O	807	808	)
O	808	809	.

B-outcome-Measure	810	818	Cosmetic
I-outcome-Measure	819	827	outcomes
O	828	832	were
O	833	846	independently
O	847	855	assessed
O	856	859	via
O	860	866	visual
O	867	875	analogue
O	876	881	scale
O	882	883	(
O	883	886	VAS
O	886	887	)
O	888	893	score
O	894	905	evaluations
O	906	908	of
O	909	916	blinded
O	917	925	incision
O	926	937	photographs
O	938	939	(
O	939	946	primary
O	947	955	endpoint
O	955	956	)
O	957	960	and
B-outcome-Measure	961	968	surgeon
I-outcome-Measure	968	969	-
I-outcome-Measure	969	977	assessed
I-outcome-Measure	978	986	modified
I-outcome-Measure	987	996	Hollander
I-outcome-Measure	997	1002	Scale
I-outcome-Measure	1003	1004	(
I-outcome-Measure	1004	1008	mHCS
I-outcome-Measure	1008	1009	)
I-outcome-Measure	1010	1016	scores
O	1017	1018	(
O	1018	1027	secondary
O	1028	1036	endpoint
O	1036	1037	)
O	1037	1038	.

O	1039	1042	SSI
O	1043	1054	assessments
O	1055	1059	used
O	1060	1064	both
O	1065	1068	CDC
O	1069	1077	criteria
O	1078	1081	and
O	1082	1089	ASEPSIS
O	1090	1096	scores
O	1096	1097	.

O	1098	1101	Six
O	1102	1109	Chinese
O	1110	1119	hospitals
O	1120	1130	randomized
B-total-participants	1131	1134	101
O	1135	1140	women
O	1141	1151	undergoing
O	1152	1160	modified
O	1161	1168	radical
O	1169	1179	mastectomy
O	1180	1182	to
O	1183	1190	closure
O	1191	1195	with
O	1196	1202	coated
O	1203	1209	VICRYL
O	1210	1214	Plus
O	1215	1221	suture
O	1222	1223	(
O	1223	1224	n
O	1225	1226	=
B-intervention-participants	1227	1229	51
O	1229	1230	)
O	1231	1233	or
O	1234	1241	Chinese
O	1242	1246	silk
O	1247	1253	suture
O	1254	1255	(
O	1255	1256	n
O	1257	1258	=
B-control-participants	1259	1261	50
O	1261	1262	)
O	1262	1263	.

B-outcome	1264	1268	Mean
I-outcome	1269	1272	VAS
I-outcome	1273	1281	cosmetic
I-outcome	1282	1289	outcome
I-outcome	1290	1296	scores
O	1297	1300	for
O	1301	1314	antibacterial
O	1315	1321	suture
O	1322	1323	(
B-iv-cont-mean	1323	1325	67
I-iv-cont-mean	1325	1326	.
I-iv-cont-mean	1326	1327	2
O	1327	1328	)
O	1329	1333	were
O	1334	1340	better
O	1341	1345	than
O	1346	1349	for
O	1350	1357	Chinese
O	1358	1362	silk
O	1363	1364	(
B-cv-cont-mean	1364	1366	45
I-cv-cont-mean	1366	1367	.
I-cv-cont-mean	1367	1368	4
O	1368	1369	)
O	1370	1372	at
O	1373	1376	day
O	1377	1379	30
O	1380	1381	(
O	1381	1382	P
O	1383	1384	<
O	1385	1386	0
O	1386	1387	.
O	1387	1391	0001
O	1391	1392	)
O	1392	1393	)
O	1393	1394	.

B-outcome	1395	1399	Mean
I-outcome	1400	1404	mHCS
I-outcome	1405	1413	cosmetic
I-outcome	1414	1421	outcome
I-outcome	1422	1427	total
I-outcome	1428	1434	scores
O	1434	1435	,
O	1436	1440	were
O	1441	1445	also
O	1446	1452	higher
O	1453	1456	for
O	1457	1470	antibacterial
O	1471	1477	suture
O	1478	1479	(
B-iv-cont-mean	1479	1480	5
I-iv-cont-mean	1480	1481	.
I-iv-cont-mean	1481	1482	7
O	1482	1483	)
O	1484	1488	than
O	1489	1492	for
O	1493	1500	Chinese
O	1501	1505	silk
O	1506	1507	(
B-cv-cont-mean	1507	1508	5
I-cv-cont-mean	1508	1509	.
I-cv-cont-mean	1509	1510	0
O	1510	1511	)
O	1512	1514	at
O	1515	1518	day
O	1519	1521	30
O	1522	1523	(
O	1523	1524	P
O	1525	1526	=
O	1527	1528	0
O	1528	1529	.
O	1529	1532	002
O	1532	1533	)
O	1533	1534	.

O	1535	1543	Patients
O	1544	1549	using
O	1550	1556	coated
O	1557	1563	VICRYL
O	1564	1568	Plus
O	1569	1575	suture
O	1576	1579	had
O	1580	1593	significantly
O	1594	1600	better
O	1601	1609	cosmetic
O	1610	1618	outcomes
O	1619	1623	than
O	1624	1629	those
O	1630	1634	with
O	1635	1642	Chinese
O	1643	1647	silk
O	1648	1655	sutures
O	1655	1656	.

O	1657	1665	Patients
O	1666	1671	using
O	1672	1678	coated
O	1679	1685	VICRYL
O	1686	1690	Plus
O	1691	1697	suture
O	1698	1701	had
O	1702	1703	a
O	1704	1709	lower
O	1710	1713	SSI
O	1714	1723	incidence
O	1724	1732	compared
O	1733	1735	to
O	1736	1739	the
O	1740	1747	Chinese
O	1748	1752	silk
O	1753	1760	sutures
O	1760	1761	,
O	1762	1770	although
O	1771	1774	the
O	1775	1785	difference
O	1786	1789	did
O	1790	1793	not
O	1794	1799	reach
O	1800	1811	statistical
O	1812	1824	significance
O	1824	1825	.
